Global 3D Medical Scanner market is projected to reach US$ 475.6 million in 2029, increasing from US$ 330.8 million in 2022, with the CAGR of 5.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to .....
SynopsisWireless portable medical devices are not limited to hospital medical devices and can be used in schools, offices, homes, and aircraft to ensure early diagnosis and better health care monitoring. The global Wireless Portable Medical Devices market size i.....
SynopsisDiphenylpyraline (DPP) is a first-generation antihistamine with anticholinergic effects of the diphenylpiperidine class. It is marketed in Europe for the treatment of allergies. DPP has also been found to act as a dopamine reuptake inhibitor and produces hyper.....
SynopsisBunionectomy indicates surgical removal of bunion i.e. enlargement of a bony bump at the base of the big toe. A bunion is comprised of soft tissue and bone and causes inflammation in the foot. This bunion causes difficulty in walking and irritation from shoes .....
SynopsisShuanghuanglian oral liquid is a traditional Chinese herbal remedy used to relieve symptoms of respiratory infections, including cough, sore throat, and fever. The global Shuanghuanglian Oral Liquid market was valued at US$ million in 2023 and is anticip.....
SynopsisPodiatry is a branch of medicine devoted to the study, diagnosis, and medical and surgical treatment of disorders of the foot, ankle and lower extremity. The global Podiatry Workstations market size is expected to reach US$ million by 2029, growing at a .....
SynopsisThe global Pentoxifylline Extended Release Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were consid.....
SynopsisThe global Ceiling-Mounted Surgical Support Arm market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considere.....
Synopsis PD-1 is an immune checkpoint inhibitor, which is relatively widely used clinically Global PD-1 Antibody Drug market is projected to reach US$ 84110 million in 2029, increasing from US$ 33000 million in 2022, with the CAGR of 14.3% during.....
SynopsisThe global Non- Alcoholic Steatohepatitis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion US.....
